Scarica l'app Stockscreener
61.53
1.20%
-0.75
Dopo l'orario di chiusura:
61.53
Precedente Chiudi:
$62.28
Aprire:
$62.32
Volume 24 ore:
436.34K
Relative Volume:
0.79
Capitalizzazione di mercato:
$3.36B
Reddito:
$1.28B
Utile/perdita netta:
$-222.15M
Rapporto P/E:
-15.04
EPS:
-4.09
Flusso di cassa netto:
$145.52M
1 W Prestazione:
-2.46%
1M Prestazione:
-3.57%
6M Prestazione:
+36.67%
1 anno Prestazione:
+32.87%
Intervallo 1D:
$61.38
$62.60
Intervallo di 1 settimana:
$61.38
$63.58
Portata 52W:
$32.48
$65.57
Livanova Plc Stock (LIVN) Company Profile
Nome
Livanova Plc
Settore
Industria
Telefono
4402033250662
Indirizzo
20 EASTBOURNE TERRACE, LONDON
Confronta LIVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
61.53 | 3.40B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
125.29 | 218.72B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
95.35 | 142.33B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
351.47 | 135.42B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.06 | 123.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.25 | 50.02B | 5.88B | 1.34B | 799.60M | 2.3489 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-20 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Iniziato | Goldman | Buy |
| 2024-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Reiterato | Needham | Buy |
| 2024-02-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-04-14 | Iniziato | Mizuho | Neutral |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-02-24 | Aggiornamento | UBS | Neutral → Buy |
| 2021-12-03 | Iniziato | Goldman | Buy |
| 2021-08-20 | Reiterato | Needham | Buy |
| 2021-07-20 | Aggiornamento | Needham | Hold → Buy |
| 2021-03-03 | Downgrade | Berenberg | Buy → Hold |
| 2021-01-05 | Downgrade | Needham | Buy → Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-06-26 | Reiterato | Needham | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-08 | Iniziato | Stifel | Buy |
| 2018-05-31 | Reiterato | Needham | Buy |
| 2018-02-28 | Reiterato | Needham | Buy |
Mostra tutto
Livanova Plc Borsa (LIVN) Ultime notizie
Precision Trading with Livanova Plc (LIVN) Risk Zones - Stock Traders Daily
LivaNova stock tests investor patience as Wall Street weighs turnaround against volatility - AD HOC NEWS
LivaNova CEO talks growth roadmap as company targets sleep apnea, depression therapies - MassDevice
LivaNova PLC $LIVN Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
LivaNova plc diskutieren - sharewise.com
LivaNova PLC (LIVN) - MSN
Voya Investment Management LLC Sells 21,244 Shares of LivaNova PLC $LIVN - MarketBeat
Vagus Nerve Stimulators Market Industry Analysis 2025-2032 - openPR.com
Adult And Pediatric Hemoconcentrators Market 2025-2032: - openPR.com
LivaNova to present at JP Morgan Healthcare Conference in January - MSN
What risks investors should watch in LivaNova PLC stockTake Profit Strategies & Explosive Profit Growth - Bollywood Helpline
LivaNova to Present at J.P. Morgan Healthcare Conference in January 2026 - BioSpace
Is Optimism Around aura6000 and Margin Upside Altering The Investment Case For LivaNova (LIVN)? - Sahm
LivaNova to Present at J.P. Morgan Healthcare Conference in January - Lelezard
LivaNova (STU:LIA) EV-to-OCF : 12.43 (As of Dec. 22, 2025) - GuruFocus
LIVN (LivaNova) EV-to-OCF : 13.15 (As of Dec. 23, 2025) - GuruFocus
How LivaNova PLC stock trades during market volatilityJuly 2025 Breakouts & Short-Term Trading Alerts - Улправда
Why LivaNova PLC stock could outperform in 20252025 Year in Review & Fast Exit/Entry Strategy Plans - Улправда
Why LivaNova PLC stock is popular among millennials2025 Fundamental Recap & Risk Controlled Daily Plans - Улправда
LivaNova (NASDAQ:LIVN) Rating Increased to Strong-Buy at KeyCorp - MarketBeat
Is LivaNova PLC stock a dividend growth opportunity2025 Top Decliners & High Accuracy Investment Entry Signals - Улправда
LivaNova (NASDAQ:LIVN) Upgraded at Wall Street Zen - MarketBeat
Is LivaNova PLC (LIA) stock prepared for digital transitionEarnings Overview Summary & Safe Capital Growth Stock Tips - Улправда
Will LivaNova PLC (LIA) stock outperform value peersRate Cut & Precise Buy Zone Tips - Улправда
How interest rate cuts could boost LivaNova PLC stock2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
LivaNova (FRA:LIA) EV-to-OCF : 12.26 (As of Dec. 19, 2025) - GuruFocus
LIVN: Analyst Initiates Coverage with Overweight Rating and $81 PT | LIVN Stock News - GuruFocus
KeyBanc Initiates LivaNova at Overweight With $81 Price Target - marketscreener.com
LIVN Stock: KeyBanc Initiates Coverage with Positive Outlook - GuruFocus
At US$62.08, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List? - Yahoo Finance
Is LivaNova PLC stock a top momentum play2025 Retail Activity & Step-by-Step Trade Execution Guides - DonanımHaber
KeyBanc initiates Livanova stock with Overweight rating, cites growth outlook By Investing.com - Investing.com Nigeria
How LivaNova PLC (LIA) stock valuation compares with sectorWeekly Gains Summary & Intraday High Probability Setup Alerts - Улправда
How buybacks impact LivaNova PLC stock valueEntry Point & Reliable Price Breakout Alerts - ulpravda.ru
[Form 4] LivaNova PLC Insider Trading Activity - Stock Titan
Fundamentals Check: Why LivaNova PLC stock could outperform in 2025Quarterly Performance Summary & Free Expert Verified Stock Movement Alerts - Улправда
Weekly Earnings: How LivaNova PLC (LIA) stock valuation compares with sectorWeekly Stock Summary & Pattern Based Trade Signal System - ulpravda.ru
Aug Analyst Calls: How buybacks impact LivaNova PLC stock valueWeekly Investment Recap & Community Driven Trade Alerts - Улправда
Mizuho Maintains LivaNova (LIVN) Outperform Recommendation - Nasdaq
Dir Podlogar Acquires 2,086 Of LivaNova PLC [LIVN] - TradingView — Track All Markets
LivaNova (NASDAQ:LIVN) Price Target Raised to $72.00 - MarketBeat
LIVN Analyst Rating: Mizuho Raises Price Target to $72.00 | LIVN Stock News - GuruFocus
Nomura Holdings Inc. Takes $3.92 Million Position in LivaNova PLC $LIVN - MarketBeat
Assessing LivaNova (LIVN)’s Valuation After Hiring ResMed Veteran to Lead Sleep Apnea Commercialization - Sahm
Published on: 2025-12-15 17:44:51 - earlytimes.in
What drives LivaNova PLC stock priceEarnings Call Summaries & Real-Life Case Studies You Can Follow - earlytimes.in
LivaNova PLC (NASDAQ:LIVN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LivaNova’s Essenz Perfusion System, UK - Medical Device Network
LivaNova PLC $LIVN Holdings Reduced by Redmile Group LLC - MarketBeat
LivaNova stock hits 52-week high at 64.46 USD By Investing.com - Investing.com Australia
LivaNova to Present at Piper Sandler Healthcare Conference in December - MSN
Livanova Plc Azioni (LIVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):